AMP Capital Investors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

AMP Capital Investors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-55,073	Closed	-$6.03M	–	1088
2021 Q3	$6.03M	Sell	55,073 -3,386	-6%	-$352K	0.03%	506
2021 Q2	$5.48M	Buy	58,459 +174	+0.3%	+$16K	0.03%	584
2021 Q1	$5.34M	Buy	58,285 +5,952	+11%	+$502K	0.03%	594
2020 Q4	$3.79M	Buy	+52,333	New	+$3.89M	0.02%	648
2020 Q3	–	Sell	-8,700	Closed	-$481K	–	1335
2020 Q2	$481K	Buy	+8,700	New	+$372K	﹤0.01%	926

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AMP Capital Investors's HZNP Position: Q4 2021 in Review

AMP Capital Investors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2021, closing a stake of 55,073 shares — an estimated $6.03M sold.

AMP Capital Investors first reported a position in HZNP in Q2 2020 and held it in 5 quarters. The position peaked at $6.03M in Q3 2021. 611 funds tracked by Wall St. Rank hold HZNP as of Q4 2021.

AMP Capital Investors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2021 after selling out during the quarter.
AMP Capital Investors sold 55,073 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2021, an estimated $6.03M.
AMP Capital Investors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 5 quarters.
AMP Capital Investors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.03M in Q3 2021.
611 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.